Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors
Man Mohan Singh(Central Drug Research Institute), Joya Chandra(The University of Texas MD Anderson Cancer Center), Christa A. Manton(The University of Texas MD Anderson Cancer Center), Krishna Bhat(The University of Texas MD Anderson Cancer Center), Wen‐Chih Tsai(The University of Texas MD Anderson Cancer Center), Kenneth Aldape(National Institutes of Health), Michelle Barton(The University of Texas MD Anderson Cancer Center)
Cited by 145
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
|Journal of Clinical Oncology|2013|1.1k
Challenges to curing primary brain tumours
|Nature Reviews Clinical Oncology|2019|965
Biological Effects of Resveratrol
|Antioxidants and Redox Signaling|2001|508